| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Clinical Outcome Following Treatment of Refractory Inflammatory andFistulizing Crohn's Disease With Intravenous Cyclosporine |
Egan, L.J.;Sandborn, W.J.;Tremaine, W.J.; |
The American Journal of Gastroenterology |
1998-03-01 |
查看 |
| Renal and Urologic Complications of Inflammatory Bowel Disease |
Pardi, D.S.;Tremaine, W.J.;Sandborn, W.J.;McCarthy, J.T.; |
The American Journal of Gastroenterology |
1998-04-01 |
查看 |
| Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms,pharmacology, and clinical results |
Sandborn, W.J.; |
The American Journal of Gastroenterology |
1999-05-01 |
查看 |
| Fecal calprotectin levels predict colorectal inflammation among patientswith chronic diarrhea referred for colonoscopy |
Limburg, P.J.;Ahlquist, D.A.;Sandborn, W.J.;Mahoney, D.W.;Devens, M.E.;Harrington, J.J.;Zinsmeister, A.R.; |
The American Journal of Gastroenterology |
2000-10-01 |
查看 |
| Intravenous azathioprine in severe ulcerative colitis: a pilot study |
Mahadevan, U.;Tremaine, W.J.;Johnson, T.;Pike, M.G.;Mays, D.C.;Lipsky, J.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2000-12-01 |
查看 |
| Early measles virus infection is associated with the development ofinflammatory bowel disease |
Pardi, D.S.;Tremaine, W.J.;Sandborn, W.J.;Loftus, E.V.;Poland, G.A.;Harmsen, W.S.;Zinsmeister, A.R.;Melton, L.J.; |
The American Journal of Gastroenterology |
2000-06-01 |
查看 |
| Risk of lymphoma in inflammatory bowel disease |
Loftus, E.V.;Tremaine, W.J.;Habermann, T.M.;Harmsen, W.S.;Zinsmeister, A.R.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Corticosteroid dependent and resistant Crohns disease |
Faubion, W.A.;Loftus, E.V.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Intravenous azathioprine in severe ulcerative colitis: a pilot study |
Mahadevan, U.;Termaine, W.J.;Johnson, T.;Pike, M.G.;Mays, D.C.;Lipsky, J.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Fistulas to the bladder and urinary tract in Crohn's disease |
Solem, C.A.;Loftus, E.V.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: thefirst 100 patients |
Ricart, E.;Panaccione, R.;Loftus, E.V.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2001-03-01 |
查看 |
| Increased eosinophil infiltration and degranulation in colonic tissue frompatients with collagenous colitis |
Levy, A.M.;Yamazaki, K.;Van Keulen, V.P.;Burgart, L.J.;Sandborn, W.J.;Phillips, S.F.;Kephart, G.M.;Gleich, G.J.;Leiferman, K.M.; |
The American Journal of Gastroenterology |
2001-05-01 |
查看 |
| Cigarette smoking and celiac sprue: a case-control study |
Patel, A.H.;Loftus, E.V.;Murray, J.A.;Harmsen, W.S.;Zinsmeister, A.R.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2001-08-01 |
查看 |
| A prospective cohort study of practice guidelines in inflammatory boweldisease |
Tremaine, W.J.;Sandborn, W.J.;Loftus, E.V.;Kenan, M.L.;Petterson, T.M.;Zinsmeister, A.R.;Silverstein, M.D.; |
The American Journal of Gastroenterology |
2001-08-01 |
查看 |
| Budesonide modified release capsules as maintenance treatment in mild tomoderate Crohn's disease |
Hanauer, S.B.;Sandborn, W.J.;Levine, J.G.;Persson, A.;Persson, T.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Preoperative azathioprine/6-mercaptopurine use is not associated withincreased complications following proctocolectomy and ileal pouch analanastomosis (IPAA) for ulcerative colitis (UC) |
Mahadevan, U.;Loftus, E.V.;Tremaine, W.J.;Pemberton, J.o.H.;Harmsen, S.W.;Schleck^2, C.D.;Zinsmeister, A.D.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Safety of selective cyclooxygenase-2 inhibitors (COX2-I) in inflammatorybowel disease (IBD) |
Mahadevan, U.;Loftus, E.V.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Lymphocytic colitis: clinical features, treatment, and outcomes |
Pardi, D.S.;Ramnath, V.R.;Loftus, E.V.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-11-01 |
查看 |
| Rational selection of oral 5-aminosalicylate formulations and prodrugs forthe treatment of ulcerative colitis |
Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-12-01 |
查看 |
| Infliximab in the treatment of Crohn's disease: a user's guide forclinicians |
Sandborn, W.J.;Hanauer, S.B.; |
The American Journal of Gastroenterology |
2002-12-01 |
查看 |
| Microscopic colitis: a review |
Pardi, D.S.;Smyrk, T.C.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-04-01 |
查看 |
| Safety of selective cyclooxygenase-2 inhibitors in inflammatory boweldisease |
Mahadevan, U.;Loftus, E.V.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-04-01 |
查看 |
| The fate of low grade dysplasia in ulcerative colitis |
Ullman, T.A.;Loftus, E.V.;Kakar, S.;Burgart, L.J.;Sandborn, W.J.;Tremaine, W.J.; |
The American Journal of Gastroenterology |
2002-04-01 |
查看 |
| N-acetyltransferase 1 and 2 genotypes do not predict response or toxicityto treatment with mesalamine and sulfasalazine in patients with ulcerativecolitis |
Ricart, E.;Taylor, W.R.;Loftus, E.V.;O'Kane, D.;Weinshilboum, R.M.;Tremaine, W.J.;Harmsen, W.S.;Zinsmeister, A.R.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-07-01 |
查看 |
| Measurement of anti-saccharomyces cerevisiae antibodies in human feces as aindicator of Crohn's Disease |
Boone, J.H.;Sandborn, W.J.;Pelanne, L.M.H.;Lyerly, D.M.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Comparable systemic absorption of 5-ASA and N-AC-5-ASA from U.S. asacol andcolazal |
Sandborn, W.J.;Hanauer, S.B.;Buch, A.B.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Isolated lymphocyte 6-thioguanine nucleotide (6TGN) concentrationscorrelate with whole blood and isolated red blood cell (RBC) 6TGNconcentrations in patients taking azathioprine (AZA) for inflammatory boweldisease (IBD) |
Thomas, C.W.;Arendt, B.K.;Myhre, G.M.;Jelinek, D.F.;Egan, L.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Dose response and metabolism of 6-mercaptopurine (6MP) and azathioprine(AZA) in a lymphoblast cell line |
Thomas, C.W.;Myhre, G.M.;Mays, D.C.;Lipsky, J.J.;Egan, L.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| The pharmacokinetic profiles of oral 5ASA formulations used in themanagement of ulcerative colitis: a systematic review |
Sandborn, W.J.;Hanauer, S.B.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Incidence of Ischemic colitis in Olmsted county, Minnesota, 1976-1998 |
Loftus, E.V.;Sandborn, W.J.;Tremaine, W.J.;Harmsen, W.S.;Zinsmeister, A.R.;Locke, G.R.;Gibbons, D.;Cook, S.;Melton, L.J.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Fistulas to the urinary system in Crohn's disease: clinical features andoutcomes |
Solem, C.A.;Loftus, E.V.;Tremaine, W.J.;Pemberton, J.H.;Wolff, B.G.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Management of Crohn's disease of the ileoanal pouch with infliximab |
Colombel, J.-F.;Ricart, E.;Loftus, E.V.;Tremaine, W.J.;Young-Fadok, T.;Dozois, E.J.;Wolff, B.G.;Devine, R.;Pemberton, J.H.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-10-01 |
查看 |
| Novel approaches to treating inflammatory bowel disease: targeting alpha-4integrin |
Sandborn, W.J.;Yednock, T.A.; |
The American Journal of Gastroenterology |
2003-11-01 |
查看 |
| Novel approaches to treating inflammatory bowel disease: targeting alpha-4integrin |
Sandborn, W.J.;Yednock, T.A.; |
The American Journal of Gastroenterology |
2003-11-01 |
查看 |
| Evidence-based treatment algorithm for mild to moderate Crohn's disease |
Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-12-01 |
查看 |
| Evidence-based treatment algorithm for mild to moderate Crohn's disease |
Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-12-01 |
查看 |
| Fecal lactoferrin is a sensitive and specific marker in identifyingintestinal inflammation |
Kane, S.V.;Sandborn, W.J.;Rufo, P.A.;Zholudev, A.;Boone, J.;Lyerly, D.;Camilleri, M.;Hanauer, S.B.; |
The American Journal of Gastroenterology |
2003-06-01 |
查看 |
| Co-administration of azathioprine and allopurinol in a patient withinflammatory bowel disease and gout: an indication for 6-thioguaninenucleotide montioring |
Thomas, C.W.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
| Cost-effectiveness analysis of thiopurine methyltransferase (TPMT)screening and metabolite monitoring (MM) in the management of azathioprine(AZA)-treated Crohn's disease (CD) patients |
Dubinsky, M.;Reyes, E.;Ofman, J.;Chiou, C.-F.;Wade, S.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
| The safety profile of Azathioprine (AZA)/6-Mercaptopurine (6-MP) in thetreatment of inflammatory bowel disease (IBD): a population-based study inOlmsted County, Minnesota |
Loftus, C.G.;Loftus, E.V.;Tremaine, W.J.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
| Fecal lactoferrin measurements are useful in the interval assessment ofpatients with active and inactive inflammatory bowel disease |
Walker, T.R.;Sandborn, W.J.;Boone, J.;Sisco, D.;Lyerly, D.;Rufo, P.A.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
| Azathioprine downregulates trail expression in a T cell line and in normalhuman peripheral blood T cells |
Thomas, C.W.;Egan, L.J.;Myhre, G.M.;Tschumper, R.C.;Rasmussen, D.L.;Raghavakaimal, S.;Charlton, M.R.;Jelinek, D.F.;Sandborn, W.J.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
|
|
